Carlotta Magrì

Dr. Carlotta Magrì

Microbiologia e Virologia, Università Cattolica del Sacro Cuore, Rome, Lazio, Italy
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
GMGiulia Menchinelli
Giulia Menchinelli
Damiano SquitieriDamiano Squitieri
Damiano Squitieri
Carlotta MagrìCarlotta Magrì
Carlotta Magrì
FMFlavio De Maio
Flavio De Maio
TDTiziana D’inzeo
Tiziana D’inzeo
Brunella PosteraroBrunella Posteraro
Brunella Posteraro
Background/Objectives: The International Organization for Standardization (ISO) 20776-2:2021, which replaces ISO 20776-2:2007, focuses solely on the performance of antimicrobial susceptibility testing (AST) assays, emphasizing the ISO 20776-1 broth microdilution method as the reference standard. Consequently, categorical agreement (CA) and associated errors should not be applied. We verified the Vitek Reveal AST assay according to both ISO 20776-2:2021 and ISO 20776-2:2007 criteria. Methods: Samples from 100 simulated and clinical Gram-negative (GN) positive blood cultures (PBCs) were tested at a large teaching hospital. The simulated GN-PBCs were obtained from a hospital collection of isolates selected to represent diverse antimicrobial resistance profiles. The Reveal assay results were compared with those from the reference assay, and the time to result (TTR) for the Reveal assay was calculated. Results: The essential agreement rates were 96.1% (816/849) for simulated and 98.8% (929/940) for clinical GN-PBC samples. The bias values were −3.1 for simulated and −11.0 for clinical samples. The CA rates were 97.7% (808/827) for simulated and 99.2% (924/931) for clinical samples. The mean TTR ± SD (hours) for resistant organisms was significantly lower (4.40 ± 1.15) than that for susceptible, increased exposure (5.52 ± 0.48) and susceptible (5.54 ± 0.49) organisms. Conclusions: Our findings reinforce the potential of the Reveal assay as a valuable tool and support its implementation in clinical microbiology laboratories.

12 November 2025 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
DSDamiano Squitieri
Damiano Squitieri
GMGiulia Menchinelli
Giulia Menchinelli
Carlotta MagrìCarlotta Magrì
Carlotta Magrì
TDTiziana D’iNzeo
Tiziana D’iNzeo
BFBarbara Fiori
Barbara Fiori
Brunella PosteraroBrunella Posteraro
Brunella Posteraro
Early antimicrobial susceptibility testing (AST) in Gram-negative (GN) bloodstream infections is critical to guide appropriate therapy. This study evaluated three rapid AST (RAST) systems—VITEK REVEAL, direct-from-blood-culture VITEK 2 (VITEK 2-RAST), and EUCAST disk diffusion (DD-RAST)—using 220 prospectively collected GN-positive blood cultures (GN-PBCs). A total of 18 GN species were tested, including Enterobacterales , Acinetobacter baumannii , and Pseudomonas aeruginosa , against 25 antibiotics, four of which were next-generation β-lactam/β-lactamase inhibitor (BL/BLI) antibiotics. Reference broth microdilution was used for comparison. The VITEK REVEAL assay showed 97.1% essential agreement (EA), −7.7 bias, and 98.3% categorical agreement (CA) across 3,603 organism/antibiotic combinations. The VITEK 2-RAST assay showed 96.2% EA, −10.4 bias, and 98.4% CA across 3,941 combinations. The DD-RAST assay showed 98.2% CA across 2,388 combinations. Among 164 GN-PBCs tested with all three assays, EA rates were 97.5% for VITEK REVEAL and 96.3% for VITEK 2-RAST, with bias values of −7.1 and −6.9, respectively. Across all three assays, the CA rate was ≥98.2%, and very major error (VME) rates were ≤1.8%. Mean time-to-result (TTR) was significantly shorter with VITEK REVEAL (6 h 32 min) compared to VITEK 2-RAST (13 h 51 min) and the fixed 8 h of DD-RAST. In resistant organisms, VITEK REVEAL produced significantly faster results than in susceptible or intermediate ones, including BL/BLI antibiotics. A. baumannii yielded the shortest TTR, with no observed VME. These results support the use of RAST directly on GN-PBCs, with VITEK REVEAL emerging as a particularly promising option for rapid and accurate testing. IMPORTANCE: This study is the first to conduct a direct comparison of three rapid antimicrobial susceptibility testing (RAST) systems—VITEK REVEAL, VITEK 2-RAST, and DD-RAST—on a large, prospectively collected cohort of Gram-negative-positive blood cultures (GN-PBCs). The data offer valuable insights for laboratories evaluating RAST implementation, especially in EUCAST-based contexts. Among the systems tested, VITEK REVEAL stood out for its combination of rapid turnaround and high accuracy, including for antibiotic-resistant organisms and β-lactam/β-lactamase inhibitor (BL/BLI) antibiotics. These findings underscore the potential of RAST systems to deliver timely and reliable susceptibility results directly from GN-PBCs, thereby supporting more effective antimicrobial stewardship and clinical decision-making. However, the real-world impact will also depend on how well these systems integrate into routine workflows, as seamless implementation can directly affect time-to-result (TTR)—an essential element in optimizing the management of GN-bloodstream infection (BSI).

26 October 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
Carlotta MagrìCarlotta Magrì
Carlotta Magrì
Elena De CarolisElena De Carolis
Elena De Carolis
VIVittorio Ivagnes
Vittorio Ivagnes
VPVINCENZO DI PILATO
VINCENZO DI PILATO
BSBram Spruijtenburg
Bram Spruijtenburg
Maurizio SanguinettiMaurizio Sanguinetti
Maurizio Sanguinetti
In 2019, Candida auris became the first fungal pathogen included in the list of the urgent antimicrobial threats by the Centers for Disease Control (CDC). Short tandem repeat (STR) analysis and whole-genome sequencing (WGS) are considered the gold standard, and can be complemented by other molecular methods, for the genomic surveillance and clade classification of this multidrug-resistant yeast. However, these methods can be expensive and require time and expertise that are not always available. The long turnaround time is especially not compatible with the speed needed to manage clonal transmission in healthcare settings. Fourier transform infrared (FTIR) spectroscopy, a biochemical fingerprint approach, has been applied in this study to a set of 74 C. auris isolates belonging to the five clades of C. auris (I-V) in combination with an artificial neural network (ANN) algorithm to create and validate “CLADE-FINDER”, a tool for C. auris clade determination. The CLADE-FINDER classifier allowed us to discriminate the four primary C. auris clades (I-IV) with a correct classification for 96% of the samples in the validation set. This newly developed genotyping scheme can be reasonably applied for the effective epidemiological monitoring and management of C. auris cases in real time.

18 October 2024 in Journal of Hospital Infection
Verified
Journal Article
Open access
BSB. Spruijtenburg
B. Spruijtenburg
Elena De CarolisElena De Carolis
Elena De Carolis
Carlotta MagrìCarlotta Magrì
Carlotta Magrì
JMJ.F. Meis
J.F. Meis
MSM. Sanguinetti
M. Sanguinetti
Eelco F.J. MeijerEelco F.J. Meijer
Eelco F.J. Meijer
Candida tropicalis is a medically important yeast with increasing antifungal resistance, but nosocomial transmission is rarely reported. This study genotyped C. tropicalis isolates from Italian hospitals to uncover potential nosocomial transmission and assess resistance. In total, 197 C. tropicalis isolates from 161 patients were collected from five centres from 2013 to 2023. Short tandem repeat (STR) genotyping was conducted on all isolates, and a selection of 24 isolates were typed with whole-genome sequencing (WGS) and the novel Fourier-transform infrared (FTIR) spectroscopy method. Antifungal resistance was investigated with microbroth dilution and WGS. STR genotyping revealed seven clusters with isolates from multiple patients. WGS single nucleotide polymorphism (SNP) analysis on five groups of isolates with related STR genotypes also separated these isolates into five groups, of which two groups contained a cluster of isolates from different patients distinguished by ≤59 SNPs. In comparison, sequential isolates within three patients were differentiated by ≤141 SNPs. The two C. tropicalis WGS clusters also clustered based on FTIR genotyping, although this method did not separate the isolates into five groups. None of the 24 isolates were resistant to common antifungals. WGS SNP analysis indicated nosocomial transmission of two lineages within the same hospital, highlighting the need for enforced infection prevention measures and routine genotyping on this common yeast in clinical settings. While both STR and FTIR genotyping also clustered these lineages, WGS SNP analysis is required to determine whether isolates were transmitted clonally.

13 February 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
Elena De CarolisElena De Carolis
Elena De Carolis
VIVittorio Ivagnes
Vittorio Ivagnes
Carlotta MagrìCarlotta Magrì
Carlotta Magrì
BFBenedetta Falasca
Benedetta Falasca
TSTeresa Spanu
Teresa Spanu
Maurizio SanguinettiMaurizio Sanguinetti
Maurizio Sanguinetti
The identification of microorganisms at the species level has always constituted a diagnostic challenge for clinical microbiology laboratories. The aim of the present study has been the evaluation in a real-time assay of the performance of Autobio in comparison with the Bruker mass spectrometry system for the identification of bacteria and yeasts. A total of 535 bacteria and yeast were tested in parallel with the two systems by direct smear or fast formic acid extraction for bacteria and yeasts, respectively. Discordant results were verified by 16S, ITS rRNA or specific gene sequencing. Beyond giving comparable results for bacteria with respect to the MBT smart system, Autof MS2600 mass spectrometer provided excellent accuracy for the identification of yeast species of clinical interest.

30 October 2024 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Elena De CarolisElena De Carolis
Elena De Carolis
Carlotta MagrìCarlotta Magrì
Carlotta Magrì
GCGiulio Camarlinghi
Giulio Camarlinghi
VIVittorio Ivagnes
Vittorio Ivagnes
BSBram Spruijtenburg
Bram Spruijtenburg
Maurizio SanguinettiMaurizio Sanguinetti
Maurizio Sanguinetti
Accurate identification and rapid genotyping of Candida parapsilosis, a significant opportunistic pathogen in healthcare settings, is crucial for managing outbreaks, timely intervention, and effective infection control measures. This study includes 24 clinical samples and 2 positive environmental surveillance swabs collected during a fluconazole-resistant Candida parapsilosis outbreak at the Tuscany Rehabilitation Clinic (Clinica di Riabilitazione Toscana, CRT), located in the province of Arezzo, Italy. Fourier-transform infrared (FTIR) spectroscopy, genetic sequencing of the ERG11 gene, and short tandem repeat (STR) analysis was applied to track the fluconazole-resistant C. parapsilosis outbreak at the CRT facility. FTIR analysis clustered the isolates into two major groups, correlating with resistance-associated ERG11 mutations (Y132F and R398I), azole resistance levels, and year of isolation. The combined use of FTIR spectroscopy and STR typing provided a comprehensive approach to identify and track fluconazole-resistant C. parapsilosis isolates, which identified specific clusters of genetically similar isolates. By comparison with feasible molecular techniques, we conclude that FTIR spectroscopy applied in real time can inform targeted infection control strategies and aid in the effective management of nosocomial infections.